156 related articles for article (PubMed ID: 9400029)
1. The protective effect of metallothionein against lipid peroxidation caused by retinoic acid in human breast cancer cells.
Hurnanen D; Chan HM; Kubow S
J Pharmacol Exp Ther; 1997 Dec; 283(3):1520-8. PubMed ID: 9400029
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.
Gucev ZS; Oh Y; Kelley KM; Rosenfeld RG
Cancer Res; 1996 Apr; 56(7):1545-50. PubMed ID: 8603400
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
Liu L; Gudas LJ
J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002
[TBL] [Abstract][Full Text] [Related]
4. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells.
Abdel-Mageed A; Agrawal KC
Cancer Gene Ther; 1997; 4(3):199-207. PubMed ID: 9171939
[TBL] [Abstract][Full Text] [Related]
5. Metallothionein 1E mRNA is highly expressed in oestrogen receptor-negative human invasive ductal breast cancer.
Jin R; Bay BH; Chow VT; Tan PH; Lin VC
Br J Cancer; 2000 Aug; 83(3):319-23. PubMed ID: 10917545
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid inhibition of insulin-like growth factor I stimulation of c-fos mRNA levels in a breast carcinoma cell line.
Li XS; Chen JC; Sheikh MS; Shao ZM; Fontana JA
Exp Cell Res; 1994 Mar; 211(1):68-73. PubMed ID: 8125161
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.
Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E
Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor expression activates the transcriptional and growth-inhibitory response to retinoids without enhanced retinoic acid receptor alpha expression.
Rosenauer A; Nervi C; Davison K; Lamph WW; Mader S; Miller WH
Cancer Res; 1998 Nov; 58(22):5110-6. PubMed ID: 9823320
[TBL] [Abstract][Full Text] [Related]
9. Effects of zinc on rat hepatoma HTC cells and primary cultured rat hepatocytes.
Steinebach OM; Wolterbeek HT
Toxicol Appl Pharmacol; 1993 Feb; 118(2):245-54. PubMed ID: 8442003
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid and ascorbic acid act synergistically in inhibiting human breast cancer cell proliferation.
Kim KN; Pie JE; Park JH; Park YH; Kim HW; Kim MK
J Nutr Biochem; 2006 Jul; 17(7):454-62. PubMed ID: 16443354
[TBL] [Abstract][Full Text] [Related]
11. ZnT2-overexpression represses the cytotoxic effects of zinc hyper-accumulation in malignant metallothionein-null T47D breast tumor cells.
Lopez V; Foolad F; Kelleher SL
Cancer Lett; 2011 May; 304(1):41-51. PubMed ID: 21353385
[TBL] [Abstract][Full Text] [Related]
12. Metallothionein expression and resistance to cisplatin in a human germ cell tumor cell line.
Koropatnick J; Kloth DM; Kadhim S; Chin JL; Cherian MG
J Pharmacol Exp Ther; 1995 Dec; 275(3):1681-7. PubMed ID: 8531144
[TBL] [Abstract][Full Text] [Related]
13. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells.
Wang P; Branch DR; Bali M; Schultz GA; Goss PE; Jin T
Biochem J; 2003 Oct; 375(Pt 1):199-205. PubMed ID: 12841847
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid differentially regulates cancer cell proliferation via dose-dependent modulation of the mitogen-activated protein kinase pathway.
Crowe DL; Kim R; Chandraratna RA
Mol Cancer Res; 2003 May; 1(7):532-40. PubMed ID: 12754300
[TBL] [Abstract][Full Text] [Related]
15. Direct reaction of H2O2 with sulfhydryl groups in HL-60 cells: zinc-metallothionein and other sites.
Quesada AR; Byrnes RW; Krezoski SO; Petering DH
Arch Biochem Biophys; 1996 Oct; 334(2):241-50. PubMed ID: 8900398
[TBL] [Abstract][Full Text] [Related]
16. 13-cis retinoic acid and all-trans retinoic acid in the regulation of the proliferation and survival of human breast cancer cell line MCF-7.
Czeczuga-Semeniuk E; Wolczyński S; Dziecioł J; Dabrowska M; Anchim T; Tomaszewska I
Cell Mol Biol Lett; 2001; 6(4):925-39. PubMed ID: 11753438
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid inhibition of human breast carcinoma proliferation is accompanied by inhibition of the synthesis of a Mr 39,000 protein.
Fontana JA; Miranda D; Mezu AB
Cancer Res; 1990 Apr; 50(7):1977-82. PubMed ID: 2317786
[TBL] [Abstract][Full Text] [Related]
18. Synergistic antiproliferative effect of human recombinant interferons and retinoic acid in cultured breast cancer cells.
Marth C; Daxenbichler G; Dapunt O
J Natl Cancer Inst; 1986 Dec; 77(6):1197-202. PubMed ID: 3099046
[TBL] [Abstract][Full Text] [Related]
19. Activation of human monocytes with lipopolysaccharide induces metallothionein expression and is diminished by zinc.
Leibbrandt ME; Koropatnick J
Toxicol Appl Pharmacol; 1994 Jan; 124(1):72-81. PubMed ID: 8291064
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid causes cell growth arrest and an increase in p27 in F9 wild type but not in F9 retinoic acid receptor beta2 knockout cells.
Li R; Faria TN; Boehm M; Nabel EG; Gudas LJ
Exp Cell Res; 2004 Mar; 294(1):290-300. PubMed ID: 14980522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
